Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
56000 participants
INTERVENTIONAL
2024-10-25
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Online Programs to Promote Colon Cancer Screening
NCT01411826
Effectiveness of an mHealth Colorectal Cancer Screening Intervention
NCT02088333
Social Media and Cancer Screening Information
NCT06712901
Uncovering the Barriers of Colorectal Cancer Screening Amongst Siblings of Colorectal Cancer Patients.
NCT03395938
Cancer Screening; Access; Awareness; Navigation
NCT04131946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will inform the feasibility of using social media for CRC screening and identify the most compelling CRC screening messages for the screen-eligible population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Message #1
This arm will receive one of five social media messages that is preferred by our target population through focus groups that are being conducted as part of a previous study.
Social media message #1
Social media message promoting colorectal cancer screening
Message #2
This arm will receive the second social media message that is preferred by our target population as identified from our previous focus group study.
Social media message #2
A different social media message promoting colorectal cancer screening
Message #3
This arm will receive the third social media message that is preferred by our target population as identified from our previous focus group study.
Social media message #3
A different social media message promoting colorectal cancer screening
Arm #4
This arm will receive the fourth social media message that is preferred by our target population as identified from our previous focus group study.
Social Media Message #4
A different social media message promoting colorectal cancer screening.
Tailored Arm
This arm will receive social media messages that will be tailored by sex.
Tailored Social Media Message
Tailored social media messages promoting colorectal cancer screening.
Control Arm
This arm will not receive any intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Social media message #1
Social media message promoting colorectal cancer screening
Social media message #2
A different social media message promoting colorectal cancer screening
Social media message #3
A different social media message promoting colorectal cancer screening
Social Media Message #4
A different social media message promoting colorectal cancer screening.
Tailored Social Media Message
Tailored social media messages promoting colorectal cancer screening.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
55 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy N. Baxter, MD, FRCSC, FACS, PhD
Role: PRINCIPAL_INVESTIGATOR
Unity Health Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Unity Health Toronto
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.